CLBT Cellebrite DI Ltd. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$14.75

Period return

-1.07 (-6.76%)

Volume

1.4M

2026-07-21O $15.14 H $15.34 L $14.67 C $14.75MA5 $15.44MA20 $15.15MA60 $13.9MA120 $13.89

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 05. 27.MediumBUY2 months ago
DA Davidson: Buy
US analyst rating / recommendation change.
2026. 05. 15.LowBUY2 months ago
Needham: Buy
US analyst rating / recommendation change.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2026. 05. 14.High2 months ago
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 02. 12.LowBUY5 months ago
Needham: Buy
US analyst rating / recommendation change.
2025. 11. 14.LowBUY8 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.
2025. 11. 14.LowBUY8 months ago
Lake Street: Buy
US analyst rating / recommendation change.
2025. 11. 14.LowBUY8 months ago
B of A Securities: Buy
US analyst rating / recommendation change.
2025. 11. 13.LowBUY8 months ago
Needham: Buy
US analyst rating / recommendation change.
2025. 09. 24.LowBUY10 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $21 · 7 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 05. 14.	After market close (AMC)	$0.11	—	—	$131.87M	—	Scheduled
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.48	—	—	$185.3M	Reported
FY2024 Q2	2023. 06. 30.	Time TBD	—	$-0.37	—	—	$147.92M	Reported
FY2023 Q2	2022. 06. 30.	Time TBD	—	$0.44	—	—	$70.39M	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	231,922	$3.2M	0.00%	—	New position
2	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	109,705	$1.98M	0.00%	—	New position

Cellebrite DI Ltd.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 27.	DA Davidson	—	Initiate coverage	— → Buy	—	DA Davidson: Buy
2026. 05. 15.	Needham	—	Maintain	Buy → Buy	—	Needham: Buy
2026. 02. 12.	Needham	—	Maintain	Buy → Buy	—	Needham: Buy
2025. 11. 14.	JP Morgan	—	Maintain	Overweight → Overweight	—	JP Morgan: Overweight
2025. 11. 14.	Lake Street	—	Maintain	Buy → Buy	—	Lake Street: Buy
2025. 11. 14.	B of A Securities	—	Maintain	Buy → Buy	—	B of A Securities: Buy